Federal regulators on Tuesday cleared British drugmaker GlaxoSmithKline's $3 billion takeover of U.S. dermatology business Stiefel Laboratories Inc.
FTC clears Glaxo's $3B buyout of dermatology firmCourtesy Newsvine - business Tue, 06/02/2009 - 10:59
Federal regulators on Tuesday cleared British drugmaker GlaxoSmithKline's $3 billion takeover of U.S. dermatology business Stiefel Laboratories Inc. Related itemsGlaxo defends safety of weight loss drug alli
Glaxo signs deal with Concert on early stage drugs
Glaxo boosts production of antiviral medication
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
Uniden TRU9496 2-Line Corded/Cordless Digital...
|
Post new comment